Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05231824 · ClinicalTrials.gov registry record · NA
Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment
A NA study of Obesity and Weight Loss, sponsored by Drexel University.
- Active
- Registry status
- NA
- Development phase
- 336
- Enrollment target
- 1
- Study location
NCT05231824: Active NA study of Obesity and Weight Loss, sponsored by Drexel University.
NCT05231824 is a NA study of Obesity and Weight Loss that is active but no longer recruiting, run by Drexel University. The registered enrollment target is 336 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05231824, a NA study of Obesity and Weight Loss, is active but no longer recruiting, sponsored by Drexel University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 336 participants
- Enrollment target
- 1
- Study location
Study Summary
Project ReLearn is testing the efficacy and cost-effectiveness of an Artificial Intelligence system for optimizing weight loss coaching. Participants are randomized to a 1-year weekly gold standard behavioral weight loss remote (video) group treatment or the AI-optimized treatment, which is made up of a combination of remote group treatment, short video call and automated message. In the AI-optimized condition, the system monitors outcomes (via wireless scale, mobile phone app, and wristworn tracker) and, each week, assigns each participant the treatments they have responding to the best, within certain time constraints.
Primary Outcome
Weight will be measured using the Fitbit Aria Air wireless scale, which is accurate to 0.2 kg. In order to maximize accuracy, we will (1) provide instructions (e.g., place scale on flat, hard surface; weigh upon waking, without clothes, after using the bathroom), (2) require participants to confirm that they are following instructions at each assessment point, (3) use an average of 5 consecutive daily weights for each timepoint, (4) remove errant weights (e.g., \>1 kg change in 1 day).
Conditions Studied
Interventions
- BEHAVIORAL Standard Behavioral Weight Loss Treatment
- BEHAVIORAL AI-optimized Behavioral Weight Loss Treatment
Study Locations (1)
Pennsylvania
- Drexel University Center for Weight, Eating and Lifestyle Science - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05231824 still lists
NCT05231824 is an interventional study that assigns participants to a tested intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Standard Behavioral Weight Loss Treatment is the first listed.
NCT05231824 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05231824 about?
NCT05231824 is a clinical study titled "Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment". Project ReLearn is testing the efficacy and cost-effectiveness of an Artificial Intelligence system for optimizing weight loss coaching. Participants are randomized to a 1-year weekly gold standard behavioral weight loss remote (video) group treatment or the AI-optimized treatment, which is made up ...
What is the current status of trial NCT05231824?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 336 participants. The study started on 2022-03-22. Estimated completion is 2026-03-31.
What conditions does trial NCT05231824 study?
This clinical trial studies the following conditions: Obesity, Weight Loss.
What interventions are being tested in trial NCT05231824?
The interventions under investigation include: Standard Behavioral Weight Loss Treatment (BEHAVIORAL), AI-optimized Behavioral Weight Loss Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05231824?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05231824 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05231824's enrollment target sits among peer trials
336 199th of 1053 higher than 855 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI